Miceli, F.; Dajci, A.; Di Girolamo, A.; Nardis, P.; Ascione, M.; Cangiano, R.; Gattuso, R.; Sterpetti, A.; di Marzo, L.; Mansour, W.
Early and Mid-Term Outcomes of Isolated Type 2 Endoleak Refractory to an Embolization Procedure. J. Clin. Med. 2025, 14, 502.
https://doi.org/10.3390/jcm14020502
AMA Style
Miceli F, Dajci A, Di Girolamo A, Nardis P, Ascione M, Cangiano R, Gattuso R, Sterpetti A, di Marzo L, Mansour W.
Early and Mid-Term Outcomes of Isolated Type 2 Endoleak Refractory to an Embolization Procedure. Journal of Clinical Medicine. 2025; 14(2):502.
https://doi.org/10.3390/jcm14020502
Chicago/Turabian Style
Miceli, Francesca, Ada Dajci, Alessia Di Girolamo, Piergiorgio Nardis, Marta Ascione, Rocco Cangiano, Roberto Gattuso, Antonio Sterpetti, Luca di Marzo, and Wassim Mansour.
2025. "Early and Mid-Term Outcomes of Isolated Type 2 Endoleak Refractory to an Embolization Procedure" Journal of Clinical Medicine 14, no. 2: 502.
https://doi.org/10.3390/jcm14020502
APA Style
Miceli, F., Dajci, A., Di Girolamo, A., Nardis, P., Ascione, M., Cangiano, R., Gattuso, R., Sterpetti, A., di Marzo, L., & Mansour, W.
(2025). Early and Mid-Term Outcomes of Isolated Type 2 Endoleak Refractory to an Embolization Procedure. Journal of Clinical Medicine, 14(2), 502.
https://doi.org/10.3390/jcm14020502
